Jane Street’s Keros Therapeutics KROS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$491K Sell
44,457
-117,552
-73% -$1.82M ﹤0.01% 8083
2025
Q4
$3.3M Sell
162,009
-446
-0.3% -$7.83K ﹤0.01% 3894
2025
Q3
$2.57M Buy
162,455
+105,174
+184% +$1.55M ﹤0.01% 4472
2025
Q2
$765K Buy
57,281
+10,336
+22% +$140K ﹤0.01% 6105
2025
Q1
$478K Sell
46,945
-54,167
-54% -$629K ﹤0.01% 6941
2024
Q4
$1.6M Buy
101,112
+40,934
+68% +$2.13M ﹤0.01% 4516
2024
Q3
$3.49M Buy
60,178
+15,281
+34% +$755K 0.01% 3456
2024
Q2
$2.05M Buy
44,897
+25,518
+132% +$1.37M ﹤0.01% 4426
2024
Q1
$1.28M Sell
19,379
-38
-0.2% -$2.25K ﹤0.01% 4947
2023
Q4
$772K Buy
19,417
+8,811
+83% +$276K ﹤0.01% 6035
2023
Q3
$338K Sell
10,606
-1,960
-16% -$73.2K ﹤0.01% 6890
2023
Q2
$505K Sell
12,566
-6,476
-34% -$284K ﹤0.01% 6309
2023
Q1
$813K Buy
+19,042
New +$962K ﹤0.01% 5411
2022
Q4
Hold
0
9684
2022
Q3
Sell
-33,356
Closed -$921K 10137
2022
Q2
$921K Buy
+33,356
New +$1.46M ﹤0.01% 5638
2022
Q1
Hold
0
10739
2020
Q3
Sell
-10,397
Closed -$390K 7610
2020
Q2
$390K Buy
+10,397
New +$320K ﹤0.01% 5445

Other funds holding KROS